Raysum Co., Ltd.

Tokyo Stock Exchange 8890.T

Raysum Co., Ltd. Shareholders' Equity for the year ending March 31, 2024: USD 412.19 M

Raysum Co., Ltd. Shareholders' Equity is USD 412.19 M for the year ending March 31, 2024, a 3.93% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Raysum Co., Ltd. Shareholders' Equity for the year ending March 31, 2023 was USD 396.60 M, a -9.63% change year over year.
Raysum Co., Ltd. Shareholders' Equity for the year ending March 31, 2022 was USD 438.85 M, a 3.71% change year over year.
Raysum Co., Ltd. Shareholders' Equity for the year ending March 31, 2021 was USD 423.15 M, a -7.21% change year over year.
Raysum Co., Ltd. Shareholders' Equity for the year ending March 31, 2020 was USD 456.02 M, a 16.71% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Tokyo Stock Exchange: 8890.T

Raysum Co., Ltd.

CEO	Mr. Tsuyoshi Komachi
IPO Date	April 5, 2001
Location	Japan
Headquarters	Kasumigaseki Common Gate West Tower
Employees	214
Sector	Health Care
Industries Hospitals & Clinics Venture Capital

Description

Raysum Co., Ltd. engages in the real estate investment business in Japan. It also operates community hostels; and a specialized surgery center that offers medical care services to assist the elderly. The company was formerly known as Recrm Research Co., Ltd. and changed its name to Raysum Co., Ltd. in 2008. Raysum Co., Ltd. was founded in 1992 and is based in Tokyo, Japan.

Key trends

Past 5 years